Toposar Alternatives Compared
Toposar | Pembrolizumab | Bleomycin |
|
---|
Toposar (etoposide) | Pembrolizumab | Bleomycin |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Small Cell Lung Cancer, Ovarian Cancer, Cancer, Testicular Cancer, Hodgkin's Lymphoma. Toposar may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bladder Cancer, Breast Cancer, Cervical Cancer, Biliary Tract Tumor, Colorectal Cancer, Endometrial Cancer, Esophageal Carcinoma, Gastric Cancer, Head and Neck Cancer, Hepatocellular... View more |
Prescription only
Prescribed for Hodgkin's Lymphoma, Squamous Cell Carcinoma, Testicular Cancer, Malignant Pleural Effusion, Non-Hodgkin's Lymphoma. bleomycin may also be used for purposes not listed in this medication guide. View more |
Related suggestions Hodgkin's Lymphoma
|
|||||||
More about Toposar (etoposide) | More about Pembrolizumab | More about Bleomycin | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Pembrolizumab has an average rating of 4.6 out of 10 from a total of 233 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 54% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Toposar side effects in more detail. |
See also: pembrolizumab side effects in more detail. |
See also: bleomycin side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all bleomycin prices |
||||||||
Dosage Forms Available | ||||||||||
|
N/A |
|
||||||||
Brand Names | ||||||||||
Other etoposide brands include: Etopophos | Keytruda | Bleo 15k | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
11 hours |
624 hours |
30 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 443 drugs are known to interact with Toposar:
|
A total of 16 drugs are known to interact with pembrolizumab:
|
A total of 261 drugs are known to interact with bleomycin:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
July 31, 1973 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.